|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
14.02(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$197.54 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
1,742,072 |
2,404,472 |
3,519,952 |
3,608,378 |
Total Sell Value |
$699,894,249 |
$883,563,199 |
$1,155,800,595 |
$1,175,475,107 |
Total People Sold |
6 |
6 |
8 |
8 |
Total Sell Transactions |
39 |
65 |
82 |
89 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Medpace Investors, Llc |
10% Owner |
|
2022-09-14 |
4 |
AB |
$152.66 |
$9,543,693 |
D/D |
62,516 |
6,018,204 |
|
52% |
|
Troendle August J. |
CEO |
|
2022-09-14 |
4 |
AB |
$152.66 |
$9,543,693 |
I/I |
62,516 |
6,018,204 |
|
52% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-13 |
4 |
AB |
$157.12 |
$9,822,514 |
D/D |
62,516 |
5,955,688 |
|
49% |
|
Troendle August J. |
CEO |
|
2022-09-13 |
4 |
AB |
$157.12 |
$9,822,514 |
I/I |
62,516 |
5,955,688 |
|
49% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-12 |
4 |
AB |
$167.58 |
$10,476,264 |
D/D |
62,515 |
5,893,172 |
|
39% |
|
Troendle August J. |
CEO |
|
2022-09-12 |
4 |
AB |
$167.58 |
$10,476,264 |
I/I |
62,515 |
5,893,172 |
|
39% |
|
Troendle August J. |
CEO |
|
2022-09-09 |
4 |
AB |
$164.33 |
$9,294,012 |
I/I |
56,557 |
5,830,657 |
|
47% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-09 |
4 |
AB |
$164.33 |
$9,294,012 |
D/D |
56,557 |
5,830,657 |
|
47% |
|
Troendle August J. |
CEO |
|
2022-09-08 |
4 |
AB |
$157.65 |
$8,916,211 |
I/I |
56,557 |
5,774,100 |
|
45% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-08 |
4 |
AB |
$157.65 |
$8,916,211 |
D/D |
56,557 |
5,774,100 |
|
45% |
|
Troendle August J. |
CEO |
|
2022-09-07 |
4 |
AB |
$150.72 |
$8,524,271 |
I/I |
56,557 |
5,717,543 |
|
49% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-07 |
4 |
AB |
$150.72 |
$8,524,271 |
D/D |
56,557 |
5,717,543 |
|
49% |
|
Troendle August J. |
CEO |
|
2022-09-06 |
4 |
AB |
$147.59 |
$8,347,248 |
I/I |
56,557 |
5,660,986 |
|
60% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-06 |
4 |
AB |
$147.59 |
$8,347,248 |
D/D |
56,557 |
5,660,986 |
|
60% |
|
Troendle August J. |
CEO |
|
2022-09-02 |
4 |
AB |
$144.98 |
$7,062,556 |
I/I |
48,714 |
5,604,429 |
|
57% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-02 |
4 |
AB |
$144.98 |
$7,062,556 |
D/D |
48,714 |
5,604,429 |
|
57% |
|
Troendle August J. |
CEO |
|
2022-09-01 |
4 |
AB |
$144.52 |
$6,080,824 |
I/I |
42,076 |
5,555,715 |
|
55% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-01 |
4 |
AB |
$144.52 |
$6,080,824 |
D/D |
42,076 |
5,555,715 |
|
55% |
|
Troendle August J. |
CEO |
|
2022-07-18 |
4 |
AB |
$145.00 |
$1,207,850 |
I/I |
8,330 |
5,513,639 |
|
46% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-07-18 |
4 |
AB |
$145.00 |
$1,207,850 |
D/D |
8,330 |
5,513,639 |
|
46% |
|
Troendle August J. |
CEO |
|
2022-07-14 |
4 |
AB |
$144.59 |
$3,222,911 |
I/I |
22,290 |
5,505,309 |
|
48% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-07-14 |
4 |
AB |
$144.59 |
$3,222,911 |
D/D |
22,290 |
5,505,309 |
|
48% |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2022-05-06 |
4 |
OE |
$32.05 |
$32,050 |
D/D |
1,000 |
14,854 |
|
- |
|
Troendle August J. |
CEO |
|
2022-03-01 |
4 |
OE |
$90.65 |
$9,065,000 |
D/D |
100,000 |
806,643 |
|
- |
|
Burwig Susan E |
Exec. VP, Operations |
|
2022-02-23 |
4 |
OE |
$28.32 |
$351,168 |
D/D |
12,400 |
20,183 |
|
- |
|
533 Records found
|
|
Page 6 of 22 |
|
|